DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) - PROTEON THERAPEUTICS INC ownership

PROTEON THERAPEUTICS INC's ticker is PRTO and the CUSIP is 74371L109. A total of 1 filers reported holding PROTEON THERAPEUTICS INC in Q1 2020. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) ownership history of PROTEON THERAPEUTICS INC
ValueSharesWeighting
Q4 2019$832,000
+161.6%
2,029,000
+65.6%
0.03%
+107.7%
Q3 2019$318,000
-37.6%
1,224,8990.0%0.01%
-27.8%
Q2 2019$510,000
-17.2%
1,224,8990.0%0.02%
-25.0%
Q1 2019$616,000
-77.8%
1,224,8990.0%0.02%
-78.4%
Q4 2018$2,781,000
+16.4%
1,224,8990.0%0.11%
+29.1%
Q3 2018$2,389,000
-20.4%
1,224,8990.0%0.09%
-18.1%
Q2 2018$3,001,000
-2.0%
1,224,8990.0%0.10%
-0.9%
Q1 2018$3,062,000
+31.6%
1,224,8990.0%0.11%
+15.2%
Q4 2017$2,327,000
-5.0%
1,224,8990.0%0.09%
-16.4%
Q3 2017$2,450,000
+31.2%
1,224,8990.0%0.11%
+10.0%
Q2 2017$1,868,000
-19.9%
1,224,899
-8.1%
0.10%
+11.1%
Q1 2017$2,332,000
-7.9%
1,332,5990.0%0.09%
-13.5%
Q4 2016$2,532,000
-82.7%
1,332,599
-15.1%
0.10%
-84.7%
Q3 2016$14,652,000
+17.6%
1,570,467
+1.2%
0.68%
+39.0%
Q2 2016$12,463,000
+27.3%
1,552,031
+22.7%
0.49%
+17.5%
Q1 2016$9,794,000
-50.1%
1,265,3430.0%0.42%
-47.5%
Q4 2015$19,625,000
+11.5%
1,265,3430.0%0.80%
+16.7%
Q3 2015$17,601,000
-22.1%
1,265,3430.0%0.68%
-9.6%
Q2 2015$22,599,000
+53.6%
1,265,3430.0%0.75%
+57.9%
Q1 2015$14,716,000
+11.8%
1,265,3430.0%0.48%
+0.8%
Q4 2014$13,160,0001,265,3430.47%
Other shareholders
PROTEON THERAPEUTICS INC shareholders Q1 2020
NameSharesValueWeighting ↓
Abingworth LLP 2,017,872$27,423,00016.02%
Monashee Investment Management LLC 77,102$1,072,0007.40%
Deer VII & Co. Ltd. 315,101$4,383,0004.15%
RA Capital Management 1,506,872$20,961,0003.01%
MPM ASSET MANAGEMENT LLC 983,381$13,679,0002.10%
Omega Fund Management, LLC 250,000$3,478,0001.96%
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 1,265,343$17,601,0000.68%
Perceptive Advisors 550,000$7,650,0000.31%
TIVERTON ASSET MANAGEMENT LLC 375,000$5,216,0000.12%
Baker Brothers Advisors 274,617$3,820,0000.04%
View complete list of PROTEON THERAPEUTICS INC shareholders